all report title image
  • Published On : Dec 2020
  • Code : CMI4324
  • Industry : Biotechnology
  • Pages : 157
  • Formats :

Platelet concentration systems are designed for safe and rapid preparation of platelet rich plasma at the point-of-care from a small amount of patient’s blood sample.

Platelet-rich plasma is a non-surgical alternative to cure areas such as orthopedics, sports medicine, dentistry, ENT, neurosurgery, ophthalmology, urology, and wound healing as well as cosmetic, cardiothoracic, and maxillofacial surgery.  

The global platelet concentration systems market is estimated to be valued at US$ 286.9 million in 2020 and is expected to exhibit a CAGR of 21.2% during the forecast period (2020-2027).

Figure 1. Global Platelet Concentration Systems Market Share (%) Analysis, By Technology, 2020

Platelet Concentration Systems  | Coherent Market Insights

Increasing technological advancements in platelet concentration systems is expected to drive the global platelet concentration systems market growth

Introduction of technologically advanced platelet concentration systems for the preparation of autologous blood concentrate is expected to increase demand for platelet concentration systems in the near future.

For instance, PEAK PRP System of DePuy Synthes prepares highly concentrated 3 ml of PRP from 27 ml of whole blood in two and half minutes.

Moreover, in 2018, APEX Biologix launched a new XCELL PRP system. The XCELL PRP system has a specialized concentrating device that helps to shorten the total processing time and reduce human error compared to other systems.

CMI table icon

Platelet Concentration Systems Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 286.99 Mn
Historical Data for: 2017 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 21.2% 2027 Value Projection: US$ 1110.45 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Technology: Apheresis Technology, Single Spin Technology, Double Spin Technology.
  • By End User: Hospital, Orthopedic Clinics, Sports Injury Centers, Ambulatory Surgical Centers.
Companies covered:

Anthrax Inc., Stryker Corporation, Johnson & Johnson’s, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp., and Nuo Therapeutics, Inc.

Growth Drivers:
  • Increasing technological advancements in platelet concentration systems
  • Increasing launches and approval of Launches and Approval of Platelet Concentration Systems
Restraints & Challenges:
  • Lack of standardization in preparation and dosage of autologous blood concentrate

Global Platelet Concentration Systems Market- Restraints

Lack of standardization in preparation and dosage of autologous blood concentrate and platelet-separation techniques is a major factor hindering growth of the market.

Global Platelet Concentration Systems Market – Regional Analysis

North America accounted for the largest share in the platelet concentration systems market in 2019 due to increasing cosmetic surgery, orthopedic surgeries, and sports injuries. For instance, according to the American society of plastic surgeons, in 2015, around 15.9 million cosmetic procedures were done in the U.S.

Furthermore, Europe is expected to observe the fastest growth during the forecast period, owing to increasing geriatric population and high adoption of knee osteoarthritis treatment by age group. For instance, according to the study ‘Osteoarthritis in Europe: Impact on health status, work productivity and use of pharmacotherapies in five European countries’ that examined the impact of peripheral joint osteoarthritis across five European countries, U.K. (43.6%), France, (25.6%), Germany, (15.2%), Spain, (8.4%), and Italy (7.1%) recorded high prevalence of peripheral joint osteoarthritis.

Figure 2. Global Platelet Concentration Systems Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Platelet Concentration Systems  | Coherent Market Insights

Global Platelet Concentration Systems Market- Competitive Landscape

Key players operating in the global platelet concentration systems market include Anthrax Inc., Stryker Corporation, Johnson & Johnson’s, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp., and Nuo Therapeutics, Inc.

Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contain bio proteins that help in healing, tissue regeneration and blood loss. Platelet rich plasma is used for the treatment of injured tendons, muscle, joints, and ligaments.

Market Dynamics

Increasing healthcare facilities for geriatric population and sports injuries has boosted growth of the market. Increasing concern of the young population about aesthetic appeal has propelled the market growth due to applications of PRP in cosmetic surgery. For instance, according to the American Society of Plastic Surgeons (ASPS) reports, platelet-rich plasma (PRP) treatment was estimated to increase by 12% from around 113,356 procedures in 2017 to around 127,394 procedures in 2018.

Furthermore, increasing number of orthopedic surgeries and sports injuries, and new product approvals are expected to propel growth of the market during the forecast period. For instance, in 2018, according to the Arthritis Foundation reports, 54 million adults and approximately 300,000 babies and children suffered from arthritis in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the global platelet concentration systems market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global platelet concentration systems market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Anthrax Inc., Stryker Corporation, Johnson & Johnson’s, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp., and Nuo Therapeutics, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
  • The global platelet concentration systems market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the platelet concentration systems market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Platelet Concentration Systems Market, By Technology:
    • Apheresis Technology
    • Single Spin Technology
    • Double Spin Technology
  • Global Platelet Concentration Systems Market, By End User:
    • Hospital
    • Orthopedic Clinics
    • Sports Injury Centers
    • Ambulatory Surgical Centers
  • Global Platelet Concentration Systems Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Technology:
        • Apheresis Technology
        • Single Spin Technology
        • Double Spin Technology
      • By End User:
        • Hospital
        • Orthopedic Clinics
        • Sports Injury Centers
        • Ambulatory Surgical Centers
    • Europe
      • By Country:
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
      • By Technology:
        • Apheresis Technology
        • Single Spin Technology
        • Double Spin Technology
      • By End User:
        • Hospital
        • Orthopedic Clinics
        • Sports Injury Centers
        • Ambulatory Surgical Centers
    • Asia Pacific
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Technology:
        • Apheresis Technology
        • Single Spin Technology
        • Double Spin Technology
      • By End User:
        • Hospital
        • Orthopedic Clinics
        • Sports Injury Centers
        • Ambulatory Surgical Centers
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Technology:
        • Apheresis Technology
        • Single Spin Technology
        • Double Spin Technology
      • By End User:
        • Hospital
        • Orthopedic Clinics
        • Sports Injury Centers
        • Ambulatory Surgical Centers
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Technology:
        • Apheresis Technology
        • Single Spin Technology
        • Double Spin Technology
      • By End User:
        • Hospital
        • Orthopedic Clinics
        • Sports Injury Centers
        • Ambulatory Surgical Centers
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Technology:
        • Apheresis Technology
        • Single Spin Technology
        • Double Spin Technology
      • By End User:
        • Hospital
        • Orthopedic Clinics
        • Sports Injury Centers
        • Ambulatory Surgical Centers
  • Company Profiles
    • Arthrex, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Stryker Corporation
    • Johnson & Johnson
    • Zimmer Biomet Holdings Inc.
    • Terumo Corporation
    • Arteriocyte Medical Systems, Inc.
    • Exactech Inc.
    • Harvest Technologies Corp.
    • Nuo Therapeutics, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The CAGR of the platelet concentration systems market is expected to be 21.2% during the forecast period (2020-2027).
The value of platelet concentration systems market is estimated to be US$ 286.9 million in 2020.
The prominent players in the global platelet concentration systems market include Anthrax Inc., Stryker Corporation, Johnson & Johnson’s, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp., and Nuo Therapeutics, Inc.
The global platelet concentration systems market is expected to be valued at US$ 1,110.45 Mn in 2027.
North America is the major region in the global platelet concentration systems market.
The increasing technological advancements in platelet concentration systems and increasing launches and approval of platelet concentration systems are expected to drive growth of the global platelet concentration systems market.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo